Ultrasound monitoring for Takayasu arteritis disease activity
Part of Heart & circulation, Skin clinical trials.
This study tests whether ultrasound can track inflammation in blood vessels for people with Takayasu arteritis (a rare condition causing vessel inflammation). You'll have regular ultrasounds to see if this method helps doctors spot disease activity early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with Takayasu arteritis using standard criteria
- Your disease is currently active (showing signs, blood test changes, or imaging changes)
- You can attend multiple ultrasound appointments over time
- You are able to have ultrasounds without medical contraindications (no conditions making ultrasound unsafe)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two new medications, vunakizumab and ivarmacitinib, for people with active Takayasu's arteritis (TAK) that is not fully controlled by standard treatments. The goal is to see if these drugs are safe and effective for reducing disease activity.
This study collects medical information from patients diagnosed with Takayasu arteritis, a rare disease affecting large blood vessels. By joining, you help researchers better understand this condition and improve care for future patients.
This study tests a new pill called deucravacitinib for people with active Takayasu's arteritis (a rare blood vessel disease). It aims to see if the drug can help control inflammation when other treatments have not worked well enough.
This UK-based study uses a questionnaire to learn about how people with Takayasu arteritis (a rare type of vasculitis) are treated and what they think about their care. If you have TAK, your answers can help doctors understand how to better manage this condition.
This study collects information and blood samples (biomarkers) to better understand Takayasu arteritis and how active it is. It may help researchers find tests that support diagnosis and track disease activity.
This is a patient registry that collects information about people with Takayasu arteritis. It helps researchers better understand the condition and how it affects blood flow in the arms and other major vessels.
Hear when a new Takayasu Arteritis (TAK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.